Cargando…
Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening
Glucose-6-phosphate dehydrogenase (G6PD) deficiency, an X-linked genetic disorder, is associated with increased risk of jaundice and kernicterus at birth. G6PD deficiency can manifest later in life as severe hemolysis, when the individual is exposed to oxidative agents that range from foods such as...
Autores principales: | Anderle, Athena, Bancone, Germana, Domingo, Gonzalo J., Gerth-Guyette, Emily, Pal, Sampa, Satyagraha, Ari W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832607/ https://www.ncbi.nlm.nih.gov/pubmed/31709308 http://dx.doi.org/10.3390/ijns4040034 |
Ejemplares similares
-
Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood
por: Bancone, Germana, et al.
Publicado: (2018) -
Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression
por: Kalnoky, Michael, et al.
Publicado: (2018) -
Development of a new software tool and analysis method to improve determination of G6PD status
por: Kalnoky, Michael, et al.
Publicado: (2014) -
Optimizing G6PD testing for
Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter
por: Chu, Cindy S, et al.
Publicado: (2020) -
Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision
por: Pal, Sampa, et al.
Publicado: (2021)